Cargando…

Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial

OBJECTIVE: To investigate the role of previous gynecologic surgery, hormone use, and use of non-steroidal anti-inflammatory drugs on the risk of type 1 and type 2 ovarian cancer. METHODS: We utilized data collected for the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. All diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terada, Keith Y., Ahn, Hyeong Jun, Kessel, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823356/ https://www.ncbi.nlm.nih.gov/pubmed/27029746 http://dx.doi.org/10.3802/jgo.2016.27.e25

Ejemplares similares

Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer
por: Lai, Tiffany, et al.
Publicado: (2016)

Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Ahn, J, et al.
Publicado: (2009)

Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials
por: Ormsby, Eleanor L., et al.
Publicado: (2017)

Using gene expression in patients with endometrial intraepithelial neoplasia to assess the risk of cancer
por: Vierkoetter, Koah, et al.
Publicado: (2018)

Randomization to Screening for Prostate, Lung, Colorectal and Ovarian Cancers and Thyroid Cancer Incidence in Two Large Cancer Screening Trials
por: O'Grady, Thomas J., et al.
Publicado: (2014)

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Leitzmann, Michael F., et al.
Publicado: (2008)

Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type
por: Gaitskell, Kezia, et al.
Publicado: (2015)

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
por: Jacobs, Ian J, et al.
Publicado: (2016)

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Menon, Usha, et al.
Publicado: (2017)

Differences in breast cancer risk after benign breast disease by type of screening diagnosis
por: Louro, Javier, et al.
Publicado: (2020)

Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis
por: Yu, Hailin, et al.
Publicado: (2023)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

Lung Cancer Screening Based on Type-different Sensor Arrays
por: Li, Wang, et al.
Publicado: (2017)

Familial risks of ovarian cancer by age at diagnosis, proband type and histology
por: Zheng, Guoqiao, et al.
Publicado: (2018)

Global epidemiology, risk factors, and histological types of ovarian cancers in Trinidad
por: Umakanthan, Srikanth, et al.
Publicado: (2019)

Multiple types of distress are prospectively associated with increased risk of ovarian cancer
por: Roberts, Andrea L., et al.
Publicado: (2023)

Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Huang, Jiaqi, et al.
Publicado: (2016)

Ovarian cancer screening
por: Rufford, B., et al.
Publicado: (2015)

The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT
por: Fallowfield, Lesley, et al.
Publicado: (2017)

Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening
por: Fallowfield, L, et al.
Publicado: (2010)

Ovarian Metastasis in Endometriod Type Endometrial Cancer
por: Gilani Modaress, Mitra, et al.
Publicado: (2011)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial
por: Dominianni, C, et al.
Publicado: (2013)

Different impacts of cancer types on cancer screening during COVID-19 pandemic in Taiwan
por: Shen, Cheng-Ting, et al.
Publicado: (2022)

Correction: Familial risks of ovarian cancer by age at diagnosis, proband type and histology
por: Zheng, Guoqiao, et al.
Publicado: (2018)

Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Hoyt, Margaret, et al.
Publicado: (2022)

Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
por: Anglesio, Michael S., et al.
Publicado: (2013)

Effect of Different Types of Mammography Equipment on Screening Outcomes: A Report by the Alliance for Breast Cancer Screening in Korea
por: Choi, Bo Hwa, et al.
Publicado: (2019)

Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Dilley, James, et al.
Publicado: (2020)

Screening for Ovarian Cancer: An Update
por: Patni, Ranu
Publicado: (2019)

Novel risk models for early detection and screening of ovarian cancer
por: Russell, Matthew R., et al.
Publicado: (2016)

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
por: Menon, Usha, et al.
Publicado: (2021)

Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
por: Ferrucci, L M, et al.
Publicado: (2009)

Detection of placental-type alkaline phosphatase in ovarian cancer.
por: McDicken, I. W., et al.
Publicado: (1985)

The effect of the type of dietary protein on the development of ovarian cancer
por: Taha, Ahmed A.A., et al.
Publicado: (2018)

Low-mass-ion discriminant equation (LOME) for ovarian cancer screening
por: Lee, Jun Hwa, et al.
Publicado: (2016)

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
por: Anglesio, Michael S., et al.
Publicado: (2013)

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
por: Anglesio, Michael S., et al.
Publicado: (2013)

When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
por: Salazar, Carolina, et al.
Publicado: (2018)

Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
por: Graff, Rebecca E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0d7ps45bseld400p2i8e2dkomb